Edit concept Question Editor Create issue ticket

Influenza Virus Vaccine

Vaccine Influenza


Presentation

  • […] between physical activity and the initial immune response to a specific antigenic challenge in the present sample of older adults.[ncbi.nlm.nih.gov]
  • The emergence of unexpected pandemic viruses presents an additional challenge to vaccine production. To increase influenza virus preparedness, much work has been dedicated to the development of a universal vaccine.[ncbi.nlm.nih.gov]
  • In recent years these efforts have resulted in the identification of novel, highly conserved epitopes for neutralizing antibodies on the influenza virus hemagglutinin protein, which are present in both the stalk and globular head domains of the molecule[ncbi.nlm.nih.gov]
  • Viruses present in the nasal and throat swab specimens and in supernatants after culturing the specimens were detected and subtyped by multiplex reverse transcriptase (RT)-PCR.[ncbi.nlm.nih.gov]
  • Abstract This study describes a method for increasing the immunogenicity of influenza virus vaccines by exploiting the natural anti-Gal antibody to effectively target vaccines to antigen-presenting cells (APC).[ncbi.nlm.nih.gov]
Biphasic Fever
  • Here, we report that naive rhesus macaques challenged with 2009 pandemic H1N1 (pH1N1) influenza virus do not develop observable clinical symptoms of disease but develop a subclinical biphasic fever on days 1 and 5 to 6 postchallenge.[ncbi.nlm.nih.gov]
Guillain-Barré Syndrome
  • If Guillain-Barré syndrome has occurred within 6 weeks of receipt of prior influenza vaccine, the decision to give FLUVIRIN should be based on careful consideration of the potential benefits and risks.[flu.seqirus.com]
  • Be sure to tell your doctor before getting vaccinated if you: Have had a life-threatening allergic reaction to a dose of the flu vaccine or any ingredient in the vaccine (like eggs or gelatin) Have had Guillain-Barré Syndrome (an immune system disorder[vaccines.gov]
  • Guillain-Barré syndrome has (very rarely) been reported (1-2 cases per million vaccinated people) [ 7 ].[patient.info]
  • Talk to your doctor to see if the vaccine is still recommended if your child: has ever had a severe reaction to a flu vaccination has had Guillain-Barré syndrome In the past, it was recommended that anyone with an egg allergy talk to a doctor about whether[m.kidshealth.org]

Treatment

  • The medium of the 23-valent pneumococcal polysaccharide vaccine treatment group had a higher antimicrobial activity than the medium of the Haemophilus influenzae type b vaccine treatment group.[ncbi.nlm.nih.gov]
  • This study demonstrates that inactivated split influenza virus vaccine is able to induce protective immune responses in healthy children, as observed in previous studies, as well as in children with recurrent wheezing who require frequent steroid treatment[ncbi.nlm.nih.gov]
  • Therefore, USP laser treatment is an attractive potential strategy to generate WIV vaccines with greater potency and safety than vaccines produced by current inactivation techniques.[ncbi.nlm.nih.gov]
  • RESULTS: The primary outcome index (percentage change in percent predicted FEV1) was not different between the two groups (0.2% vs. 0.4% for the treatment and placebo groups, respectively; P 0.78).[ncbi.nlm.nih.gov]
  • A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.[webmd.com]

Etiology

  • Fever, respiratory infection The decision to administer or to delay vaccination with the influenza virus vaccine because of current or recent febrile illness depends on the severity of symptoms and on the etiology of the disease.[pdr.net]

Epidemiology

  • 3, January 2019 Publication Influenza virus characterisation, Summary Europe, December 2018 Data Weekly influenza update, week 2, January 2019 Publication Communicable disease threats report, 13-19 January 2019, week 3 Event ISIRV and ECDC influenza epidemiology[ecdc.europa.eu]
  • During this meeting, the advisory committee reviewed and evaluated the surveillance data related to epidemiology and antigenic characteristics of recent influenza isolates, serological responses to 2016-2017 vaccines, and the availability of candidate[fda.gov]
  • Influenza A Virus, H3N2 Subtype/isolation & purification Influenza B virus/immunology Influenza B virus/isolation & purification Influenza Vaccines/administration & dosage Influenza Vaccines/adverse effects* Influenza Vaccines/immunology* Influenza, Human/epidemiology[ncbi.nlm.nih.gov]
  • Network: ECDC European Antibiotic Awareness Day ESCAIDE - Scientific conference Eurosurveillance journal LOGIN CONTACT SUPPORT Europe's journal on infectious disease surveillance, epidemiology, prevention and control Home Current Archives Eurosurveillance[eurosurveillance.org]
  • Influenza vaccines The World Health Organization reviews the world epidemiological situation twice annually and if necessary recommends new vaccine strain(s) in accordance with the available evidence.[who.int]
Sex distribution
Age distribution

Prevention

  • Abstract Although influenza vaccine delivery strategies have improved coverage rates to unprecedented levels nationally among persons aged 65 years and older, influenza remains one of the greatest vaccine-preventable threats to public health among elderly[ncbi.nlm.nih.gov]
  • S-IgA antibodies are highly effective at preventing virus infection.[ncbi.nlm.nih.gov]
  • Overall, vaccine was 92% efficacious at preventing culture-confirmed infection by influenza A/H3N2 and influenza B.[ncbi.nlm.nih.gov]
  • Increasing the incidence of elevated IgA response may prevent influenza at its early stages thus reducing complications in the elderly.[ncbi.nlm.nih.gov]
  • Author information 1 a Anhui Provincial Center for Disease Control and Prevention , Hefei , China. 2 b Sinovac Biotech Co., Ltd Beijing , China. 3 c Guxian County Center for Disease Control and Prevention , Bengbu , China.[ncbi.nlm.nih.gov]

Ask Question

5000 Characters left Format the text using: # Heading, **bold**, _italic_. HTML code is not allowed.
By publishing this question you agree to the TOS and Privacy policy.
• Use a precise title for your question.
• Ask a specific question and provide age, sex, symptoms, type and duration of treatment.
• Respect your own and other people's privacy, never post full names or contact information.
• Inappropriate questions will be deleted.
• In urgent cases contact a physician, visit a hospital or call an emergency service!